Recurrent Diffuse Intrinsic Pontine Glioma Clinical Trials

7 clinical trials for Recurrent Diffuse Intrinsic Pontine Glioma across international registries, including 3 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Lutathera for Treatment of Recurrent or Progressive High-Grade CNS Tumors — RECRUITING · PHASE1
• Combination Therapy for the Treatment of Diffuse Midline Gliomas — RECRUITING · PHASE2
• CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma — RECRUITING · PHASE1
• Savolitinib in Treating Patients With Recurrent or Refractory Primary CNS Tumors — ACTIVE_NOT_RECRUITING · PHASE1
• Pembrolizumab in Treating Younger Patients With Recurrent, Progressive, or Refractory High-Grade Gliomas, Diffuse Intrinsic Pontine Gliomas, Hypermutated Brain Tumors, Ependymoma or Medulloblastoma — ACTIVE_NOT_RECRUITING · PHASE1
• Hypofractionated Radiotherapy for Recurrent DIPG — COMPLETED · NA
• Ribociclib and Everolimus in Treating Children With Recurrent or Refractory Malignant Brain Tumors — COMPLETED · PHASE1

Refine this search